Skip to main content
Top
Published in: Current Treatment Options in Cardiovascular Medicine 4/2018

01-04-2018 | Cardio-oncology (M Fradley, Section Editor)

Evaluation and Management of Cardiac Tumors

Authors: Nicolas Palaskas, MD, Kara Thompson, MD, Gregory Gladish, MD, Ali M. Agha, MD, Saamir Hassan, MD, Cezar Iliescu, MD, Peter Kim, MD, Jean B. Durand, MD, Juan C. Lopez-Mattei, MD

Published in: Current Treatment Options in Cardiovascular Medicine | Issue 4/2018

Login to get access

Abstract

Purpose of review

Our purpose is to discuss the importance of multimodality imaging in the assessment of cardiac tumors and management. We have compiled a recent review of the scientific literature and embedded our clinical pathways and recommendations based on data and clinical experience.

Recent findings

The use of contrast echocardiography in the assessment of cardiac masses has been shown to be helpful in distinguishing tumor from thrombus. Deformation imaging of cardiac tumors has been shown to differentiate better rhabdomyomas from fibromas in pediatric patients. Cardiac MRI (CMR) appears to be helpful in determining whether cardiac tumors are benign or malignant by identifying presence of infiltration, uptake of contrast in first pass perfusion and gadolinium enhancement. Patients with evidence of cardiac metastases by CMR show similar survival to stage IV cancer without cardiac metastases. In our institution, we use a standardized approach for the evaluation of cardiac masses, which includes multimodality imaging in the appropriate clinical context. The autotransplantation surgical technique has shown some promise in improving survival in patients with primary cardiac sarcomas. In our institution, we do not routinely recommend anticoagulation for “tumor-thrombus” in renal cell carcinoma due to risk of bleeding from primary tumor.

Summary

Cardiac masses are often found incidentally, but sometimes can present with cardiovascular symptoms due to obstruction and valvular dysfunction, which may prompt imaging. It is important to determine whether the mass is a normal variant, imaging artifact, vegetation, thrombus, or tumor. Transthoracic echocardiography is ideally suited to be the initial imaging modality because of the portability, wide availability, lack of radiation, and relatively low cost. The gold standard cardiac imaging technique to distinguish tumor from thrombus is contrast enhanced CMR with prolonged inversion time. Advantages of CMR when compared to echocardiography regarding characterization of cardiac tumors are as follows: larger field of view, better spatial resolution, better tissue characterization, lack of attenuation, and ability to image at any prescribed plane. Primary and secondary cardiac tumors have particular characteristics in echocardiography and CMR. Imaging of cardiac tumors plays an important role in establishing a diagnosis and in planning management.
Literature
1.
go back to reference • Hudzik B, et al. Malignant tumors of the heart. Cancer Epidemiol. 2015;39(5):665–72. Updated review on malignant tumors of the heart, a good referenceCrossRefPubMed • Hudzik B, et al. Malignant tumors of the heart. Cancer Epidemiol. 2015;39(5):665–72. Updated review on malignant tumors of the heart, a good referenceCrossRefPubMed
2.
3.
go back to reference •• Bertrand PB, et al. Fact or artifact in two-dimensional echocardiography: avoiding misdiagnosis and missed diagnosis. J Am Soc Echocardiogr. 2016;29(5):381–91. Thorough review on artifacts in echocardiography commonly seen in clinical practiceCrossRefPubMedPubMedCentral •• Bertrand PB, et al. Fact or artifact in two-dimensional echocardiography: avoiding misdiagnosis and missed diagnosis. J Am Soc Echocardiogr. 2016;29(5):381–91. Thorough review on artifacts in echocardiography commonly seen in clinical practiceCrossRefPubMedPubMedCentral
5.
go back to reference Alam M. Pitfalls in the echocardiographic diagnosis of intracardiac and extracardiac masses. Echocardiography. 1993;10(2):181–91.CrossRefPubMed Alam M. Pitfalls in the echocardiographic diagnosis of intracardiac and extracardiac masses. Echocardiography. 1993;10(2):181–91.CrossRefPubMed
6.
go back to reference Martin RP, et al. Clinical utility of two dimensional echocardiography in infective endocarditis. Am J Cardiol. 1980;46(3):379–85.CrossRefPubMed Martin RP, et al. Clinical utility of two dimensional echocardiography in infective endocarditis. Am J Cardiol. 1980;46(3):379–85.CrossRefPubMed
8.
go back to reference Jaffe W, Figueredo VM. An example of Lambl’s excrescences by transesophageal echocardiogram: a commonly misinterpreted lesion. Echocardiography. 2007;24(10):1086–9.CrossRefPubMed Jaffe W, Figueredo VM. An example of Lambl’s excrescences by transesophageal echocardiogram: a commonly misinterpreted lesion. Echocardiography. 2007;24(10):1086–9.CrossRefPubMed
9.
go back to reference Tower-Rader A, Kwon D. Pericardial masses, cysts and diverticula: a comprehensive review using multimodality imaging. Prog Cardiovasc Dis. 2017;59(4):389–97.CrossRefPubMed Tower-Rader A, Kwon D. Pericardial masses, cysts and diverticula: a comprehensive review using multimodality imaging. Prog Cardiovasc Dis. 2017;59(4):389–97.CrossRefPubMed
10.
11.
go back to reference Tao TY, et al. Pediatric cardiac tumors: clinical and imaging features. Radiographics. 2014;34(4):1031–46.CrossRefPubMed Tao TY, et al. Pediatric cardiac tumors: clinical and imaging features. Radiographics. 2014;34(4):1031–46.CrossRefPubMed
13.
go back to reference Gowda RM, et al. Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases. Am Heart J. 2003;146(3):404–10.CrossRefPubMed Gowda RM, et al. Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases. Am Heart J. 2003;146(3):404–10.CrossRefPubMed
14.
go back to reference Bass JL, Breningstall GN, Swaiman KF. Echocardiographic incidence of cardiac rhabdomyoma in tuberous sclerosis. Am J Cardiol. 1985;55(11):1379–82.CrossRefPubMed Bass JL, Breningstall GN, Swaiman KF. Echocardiographic incidence of cardiac rhabdomyoma in tuberous sclerosis. Am J Cardiol. 1985;55(11):1379–82.CrossRefPubMed
15.
go back to reference King SJ, Smallhorn JF, Burrows PE. Epicardial lipoma: imaging findings. AJR Am J Roentgenol. 1993;160(2):261–2.CrossRefPubMed King SJ, Smallhorn JF, Burrows PE. Epicardial lipoma: imaging findings. AJR Am J Roentgenol. 1993;160(2):261–2.CrossRefPubMed
17.
go back to reference Osranek M, et al. Echocardiographic features of pheochromocytoma of the heart. Am J Cardiol. 2003;91(5):640–3.CrossRefPubMed Osranek M, et al. Echocardiographic features of pheochromocytoma of the heart. Am J Cardiol. 2003;91(5):640–3.CrossRefPubMed
18.
go back to reference Araoz PA, et al. CT and MR imaging of benign primary cardiac neoplasms with echocardiographic correlation. Radiographics. 2000;20(5):1303–19.CrossRefPubMed Araoz PA, et al. CT and MR imaging of benign primary cardiac neoplasms with echocardiographic correlation. Radiographics. 2000;20(5):1303–19.CrossRefPubMed
19.
go back to reference Burke A, Johns JP, Virmani R. Hemangiomas of the heart. A clinicopathologic study of ten cases. Am J Cardiovasc Pathol. 1990;3(4):283–90.PubMed Burke A, Johns JP, Virmani R. Hemangiomas of the heart. A clinicopathologic study of ten cases. Am J Cardiovasc Pathol. 1990;3(4):283–90.PubMed
20.
go back to reference Kojima S, et al. Cardiac hemangioma: a report of two cases and review of the literature. Heart Vessel. 2003;18(3):153–6.CrossRef Kojima S, et al. Cardiac hemangioma: a report of two cases and review of the literature. Heart Vessel. 2003;18(3):153–6.CrossRef
21.
go back to reference Kupsky DF, et al. Echocardiographic features of cardiac angiosarcomas: the Mayo Clinic experience (1976–2013). Echocardiography. 2016;33(2):186–92.CrossRefPubMed Kupsky DF, et al. Echocardiographic features of cardiac angiosarcomas: the Mayo Clinic experience (1976–2013). Echocardiography. 2016;33(2):186–92.CrossRefPubMed
23.
go back to reference Kurosawa T, et al. Primary malignant pericardial mesothelioma with increased serum mesothelin diagnosed by surgical pericardial resection: a case report. Mol Clin Oncol. 2016;5(5):553–6.CrossRefPubMedPubMedCentral Kurosawa T, et al. Primary malignant pericardial mesothelioma with increased serum mesothelin diagnosed by surgical pericardial resection: a case report. Mol Clin Oncol. 2016;5(5):553–6.CrossRefPubMedPubMedCentral
24.
go back to reference Istomin V, et al. Pericardial effusion due to primary malignant pericardial mesothelioma: a common finding but an uncommon cause. Case Rep Med. 2016;2016:4810901.CrossRefPubMedPubMedCentral Istomin V, et al. Pericardial effusion due to primary malignant pericardial mesothelioma: a common finding but an uncommon cause. Case Rep Med. 2016;2016:4810901.CrossRefPubMedPubMedCentral
25.
go back to reference Barroso AS, et al. Pericardial mesothelioma presenting as a suspected ST-elevation myocardial infarction. Rev Port Cardiol. 2017;36(4):307.e1–5. Barroso AS, et al. Pericardial mesothelioma presenting as a suspected ST-elevation myocardial infarction. Rev Port Cardiol. 2017;36(4):307.e1–5.
26.
go back to reference Salcedo EE, et al. Cardiac tumors: diagnosis and management. Curr Probl Cardiol. 1992;17(2):73–137.CrossRefPubMed Salcedo EE, et al. Cardiac tumors: diagnosis and management. Curr Probl Cardiol. 1992;17(2):73–137.CrossRefPubMed
27.
go back to reference Wood A, et al. Metastatic malignant melanoma manifesting as an intracardiac mass. Cardiovasc Pathol. 2010;19(3):153–7.CrossRefPubMed Wood A, et al. Metastatic malignant melanoma manifesting as an intracardiac mass. Cardiovasc Pathol. 2010;19(3):153–7.CrossRefPubMed
28.
go back to reference Abdelmoneim SS, et al. Assessment of the vascularity of a left atrial mass using myocardial perfusion contrast echocardiography. Echocardiography. 2008;25(5):517–20.CrossRefPubMed Abdelmoneim SS, et al. Assessment of the vascularity of a left atrial mass using myocardial perfusion contrast echocardiography. Echocardiography. 2008;25(5):517–20.CrossRefPubMed
29.
go back to reference Kirkpatrick JN, et al. Differential diagnosis of cardiac masses using contrast echocardiographic perfusion imaging. J Am Coll Cardiol. 2004;43(8):1412–9.CrossRefPubMed Kirkpatrick JN, et al. Differential diagnosis of cardiac masses using contrast echocardiographic perfusion imaging. J Am Coll Cardiol. 2004;43(8):1412–9.CrossRefPubMed
30.
go back to reference Ganame J, D’Hooge J, Mertens L. Different deformation patterns in intracardiac tumors. Eur J Echocardiogr. 2005;6(6):461–4.CrossRefPubMed Ganame J, D’Hooge J, Mertens L. Different deformation patterns in intracardiac tumors. Eur J Echocardiogr. 2005;6(6):461–4.CrossRefPubMed
31.
go back to reference Hendel RC, et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol. 2006;48(7):1475–97.CrossRefPubMed Hendel RC, et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol. 2006;48(7):1475–97.CrossRefPubMed
32.
go back to reference Beroukhim RS, et al. Characterization of cardiac tumors in children by cardiovascular magnetic resonance imaging: a multicenter experience. J Am Coll Cardiol. 2011;58(10):1044–54.CrossRefPubMed Beroukhim RS, et al. Characterization of cardiac tumors in children by cardiovascular magnetic resonance imaging: a multicenter experience. J Am Coll Cardiol. 2011;58(10):1044–54.CrossRefPubMed
33.
go back to reference Weinsaft JW, et al. LV thrombus detection by routine echocardiography: insights into performance characteristics using delayed enhancement CMR. JACC Cardiovasc Imaging. 2011;4(7):702–12.CrossRefPubMedPubMedCentral Weinsaft JW, et al. LV thrombus detection by routine echocardiography: insights into performance characteristics using delayed enhancement CMR. JACC Cardiovasc Imaging. 2011;4(7):702–12.CrossRefPubMedPubMedCentral
34.
35.
go back to reference Colin GC, et al. Cardiac myxoma imaging features and tissue characteristics at cardiovascular magnetic resonance. Int J Cardiol. 2016;202:950–1.CrossRefPubMed Colin GC, et al. Cardiac myxoma imaging features and tissue characteristics at cardiovascular magnetic resonance. Int J Cardiol. 2016;202:950–1.CrossRefPubMed
36.
go back to reference Rahsepar AA, et al. A papillary fibroelastoma involving aortic and pulmonary valves: findings on multimodality imaging. Ann Thorac Surg. 2017;103(1):e73–5.CrossRefPubMed Rahsepar AA, et al. A papillary fibroelastoma involving aortic and pulmonary valves: findings on multimodality imaging. Ann Thorac Surg. 2017;103(1):e73–5.CrossRefPubMed
37.
go back to reference •• Pazos-Lopez P, et al. Value of CMR for the differential diagnosis of cardiac masses. JACC Cardiovasc Imaging. 2014;7(9):896–905. Very important study that validates the usefulness of CMR in the evaluation of cardiac masses. Describes the features of malignant and benign tumors in CMRCrossRefPubMed •• Pazos-Lopez P, et al. Value of CMR for the differential diagnosis of cardiac masses. JACC Cardiovasc Imaging. 2014;7(9):896–905. Very important study that validates the usefulness of CMR in the evaluation of cardiac masses. Describes the features of malignant and benign tumors in CMRCrossRefPubMed
38.
go back to reference • Lopez-Mattei J, et al. The role of cardiac MRI in cardio-oncology. Futur Cardiol. 2017;13(4):311–6. This review from our center illustrates the role of CMR in our practiceCrossRef • Lopez-Mattei J, et al. The role of cardiac MRI in cardio-oncology. Futur Cardiol. 2017;13(4):311–6. This review from our center illustrates the role of CMR in our practiceCrossRef
39.
go back to reference Kim MP, et al. Outcomes after right-side heart sarcoma resection. Ann Thorac Surg. 2011;91(3):770–6.CrossRefPubMed Kim MP, et al. Outcomes after right-side heart sarcoma resection. Ann Thorac Surg. 2011;91(3):770–6.CrossRefPubMed
40.
go back to reference •• Pun, S.C., et al.. Pattern and prognostic implications of cardiac metastases among patients with advanced systemic cancer assessed with cardiac magnetic resonance imaging. J Am Heart Assoc. 2016. 5(5). Important study that emphasize the role of CMR in diagnosing metastatic disease and its relation with staging cancer patients in certain clinical scenarios. •• Pun, S.C., et al.. Pattern and prognostic implications of cardiac metastases among patients with advanced systemic cancer assessed with cardiac magnetic resonance imaging. J Am Heart Assoc. 2016. 5(5). Important study that emphasize the role of CMR in diagnosing metastatic disease and its relation with staging cancer patients in certain clinical scenarios.
41.
go back to reference • Lopez-Mattei, J. Chapter 9. Evaluation of a Cardiac Mass, in MD Anderson Practices in Onco-cardiology, Editor: Edward T.H. Yeh, M.D., F.A.C.C. 2016. p 29–30. This is a summary of our standardized approach of cardiac masses evaluation. • Lopez-Mattei, J. Chapter 9. Evaluation of a Cardiac Mass, in MD Anderson Practices in Onco-cardiology, Editor: Edward T.H. Yeh, M.D., F.A.C.C. 2016. p 29–30. This is a summary of our standardized approach of cardiac masses evaluation.
42.
go back to reference Zatorska K, et al. The usefulness of magnetic resonance imaging in the diagnosis of infectious endocarditis. J Heart Valve Dis. 2015;24(6):767–75.PubMed Zatorska K, et al. The usefulness of magnetic resonance imaging in the diagnosis of infectious endocarditis. J Heart Valve Dis. 2015;24(6):767–75.PubMed
44.
go back to reference Colucci WS, Schoen FJ, Braunwald E. Primary tumors of the heart. In: Braunwald E, editor. Heart disease: a textbook of cardiovascular medicine. Philadelphia: W.B. Saunders Company; 1997. p. 1464–77. Colucci WS, Schoen FJ, Braunwald E. Primary tumors of the heart. In: Braunwald E, editor. Heart disease: a textbook of cardiovascular medicine. Philadelphia: W.B. Saunders Company; 1997. p. 1464–77.
45.
go back to reference Blackmon SH, Reardon MJ. Cardiac neoplasms. In: Cohn LH, editor. Cardiac surgery in the adult. New York: McGraw-Hill Medical; 2012. Blackmon SH, Reardon MJ. Cardiac neoplasms. In: Cohn LH, editor. Cardiac surgery in the adult. New York: McGraw-Hill Medical; 2012.
46.
go back to reference Ngaage DL, et al. Surgical treatment of cardiac papillary fibroelastoma: a single center experience with eighty-eight patients. Ann Thorac Surg. 2005;80(5):1712–8.CrossRefPubMed Ngaage DL, et al. Surgical treatment of cardiac papillary fibroelastoma: a single center experience with eighty-eight patients. Ann Thorac Surg. 2005;80(5):1712–8.CrossRefPubMed
47.
go back to reference Sun JP, et al. Clinical and echocardiographic characteristics of papillary fibroelastomas: a retrospective and prospective study in 162 patients. Circulation. 2001;103(22):2687–93.CrossRefPubMed Sun JP, et al. Clinical and echocardiographic characteristics of papillary fibroelastomas: a retrospective and prospective study in 162 patients. Circulation. 2001;103(22):2687–93.CrossRefPubMed
48.
49.
go back to reference Bossert T, et al. Cardiac fibroma as an inherited manifestation of nevoid basal-cell carcinoma syndrome. Tex Heart Inst J. 2006;33(1):88–90.PubMedPubMedCentral Bossert T, et al. Cardiac fibroma as an inherited manifestation of nevoid basal-cell carcinoma syndrome. Tex Heart Inst J. 2006;33(1):88–90.PubMedPubMedCentral
50.
go back to reference Neragi-Miandoab S, Kim J, Vlahakes GJ. Malignant tumours of the heart: a review of tumour type, diagnosis and therapy. Clin Oncol (R Coll Radiol). 2007;19(10):748–56.CrossRef Neragi-Miandoab S, Kim J, Vlahakes GJ. Malignant tumours of the heart: a review of tumour type, diagnosis and therapy. Clin Oncol (R Coll Radiol). 2007;19(10):748–56.CrossRef
52.
go back to reference Balasundaram S, Halees SA, Duran C. Mesothelioma of the atrioventricular node: first successful follow-up after excision. Eur Heart J. 1992;13(5):718–9.CrossRefPubMed Balasundaram S, Halees SA, Duran C. Mesothelioma of the atrioventricular node: first successful follow-up after excision. Eur Heart J. 1992;13(5):718–9.CrossRefPubMed
53.
go back to reference Bruckner BA, Reardon MJ. Benign cardiac tumors: a review. Methodist Debakey Cardiovasc J. 2010;6(3):20–6.CrossRefPubMed Bruckner BA, Reardon MJ. Benign cardiac tumors: a review. Methodist Debakey Cardiovasc J. 2010;6(3):20–6.CrossRefPubMed
56.
go back to reference Simpson L, et al. Malignant primary cardiac tumors: review of a single institution experience. Cancer. 2008;112(11):2440–6.CrossRefPubMed Simpson L, et al. Malignant primary cardiac tumors: review of a single institution experience. Cancer. 2008;112(11):2440–6.CrossRefPubMed
57.
58.
go back to reference Reardon MJ, Walkes JC, Benjamin R. Therapy insight: malignant primary cardiac tumors. Nat Clin Pract Cardiovasc Med. 2006;3(10):548–53.CrossRefPubMed Reardon MJ, Walkes JC, Benjamin R. Therapy insight: malignant primary cardiac tumors. Nat Clin Pract Cardiovasc Med. 2006;3(10):548–53.CrossRefPubMed
59.
60.
go back to reference Ravi V, Benjamin RS. Systemic therapy for cardiac sarcomas. Methodist Debakey Cardiovasc J. 2010;6(3):57–60.CrossRefPubMed Ravi V, Benjamin RS. Systemic therapy for cardiac sarcomas. Methodist Debakey Cardiovasc J. 2010;6(3):57–60.CrossRefPubMed
61.
go back to reference Leja MJ, et al. Metastatic melanoma to the intracavitary left ventricle treated using cardiac autotransplantation technique for resection. Methodist Debakey Cardiovasc J. 2011;7(4):44–6.CrossRefPubMed Leja MJ, et al. Metastatic melanoma to the intracavitary left ventricle treated using cardiac autotransplantation technique for resection. Methodist Debakey Cardiovasc J. 2011;7(4):44–6.CrossRefPubMed
62.
63.
go back to reference Blackmon SH, Reardon MJ. Pulmonary artery sarcoma. Methodist Debakey Cardiovasc J. 2010;6(3):38–43.CrossRefPubMed Blackmon SH, Reardon MJ. Pulmonary artery sarcoma. Methodist Debakey Cardiovasc J. 2010;6(3):38–43.CrossRefPubMed
64.
go back to reference Yusuf SW, et al. Cardiac tumors in a tertiary care cancer hospital: clinical features, echocardiographic findings, treatment and outcomes. Heart Int. 2012;7(1):e4.CrossRefPubMedPubMedCentral Yusuf SW, et al. Cardiac tumors in a tertiary care cancer hospital: clinical features, echocardiographic findings, treatment and outcomes. Heart Int. 2012;7(1):e4.CrossRefPubMedPubMedCentral
65.
go back to reference Ceresoli GL, et al. Primary cardiac lymphoma in immunocompetent patients: diagnostic and therapeutic management. Cancer. 1997;80(8):1497–506.CrossRefPubMed Ceresoli GL, et al. Primary cardiac lymphoma in immunocompetent patients: diagnostic and therapeutic management. Cancer. 1997;80(8):1497–506.CrossRefPubMed
66.
go back to reference Petrich A, Cho SI, Billett H. Primary cardiac lymphoma: an analysis of presentation, treatment, and outcome patterns. Cancer. 2011;117(3):581–9.CrossRefPubMed Petrich A, Cho SI, Billett H. Primary cardiac lymphoma: an analysis of presentation, treatment, and outcome patterns. Cancer. 2011;117(3):581–9.CrossRefPubMed
67.
go back to reference Bambury R, et al. Primary cardiac lymphoma: diagnostic tools and treatment challenges. Ir J Med Sci. 2011;180(1):271–3.CrossRefPubMed Bambury R, et al. Primary cardiac lymphoma: diagnostic tools and treatment challenges. Ir J Med Sci. 2011;180(1):271–3.CrossRefPubMed
68.
go back to reference Woodruff DY, et al. The perioperative management of an inferior vena caval tumor thrombus in patients with renal cell carcinoma. Urol Oncol. 2013;31(5):517–21.CrossRefPubMed Woodruff DY, et al. The perioperative management of an inferior vena caval tumor thrombus in patients with renal cell carcinoma. Urol Oncol. 2013;31(5):517–21.CrossRefPubMed
69.
go back to reference Nesbitt JC, et al. Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Ann Thorac Surg. 1997;63(6):1592–600.CrossRefPubMed Nesbitt JC, et al. Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Ann Thorac Surg. 1997;63(6):1592–600.CrossRefPubMed
70.
go back to reference Wood, C.G., Anticoagulation for renal IVC tumor thrombus, Thompson KA, editor. 2013. Wood, C.G., Anticoagulation for renal IVC tumor thrombus, Thompson KA, editor. 2013.
71.
go back to reference Reardon MJ. Cardiac tumor issue overview. Methodist Debakey Cardiovasc J. 2010;6(3):2–3.CrossRef Reardon MJ. Cardiac tumor issue overview. Methodist Debakey Cardiovasc J. 2010;6(3):2–3.CrossRef
Metadata
Title
Evaluation and Management of Cardiac Tumors
Authors
Nicolas Palaskas, MD
Kara Thompson, MD
Gregory Gladish, MD
Ali M. Agha, MD
Saamir Hassan, MD
Cezar Iliescu, MD
Peter Kim, MD
Jean B. Durand, MD
Juan C. Lopez-Mattei, MD
Publication date
01-04-2018
Publisher
Springer US
Published in
Current Treatment Options in Cardiovascular Medicine / Issue 4/2018
Print ISSN: 1092-8464
Electronic ISSN: 1534-3189
DOI
https://doi.org/10.1007/s11936-018-0625-z

Other articles of this Issue 4/2018

Current Treatment Options in Cardiovascular Medicine 4/2018 Go to the issue

Heart Failure (W Tang, Section Editor)

Sleep Apnea in Heart Failure